Earnings Call · Q3 FY2023·2023-11-14

Q3 23EPS -36.36%·Rev n/aQ2 23EPS -6.94%·Rev n/aQ1 23EPS +18.31%·Rev n/aQ4 22EPS n/a·Rev n/a⚠ consensus missing

Iterum Therapeutics plc ITRMF

Louise Barrett — Senior Vice President, Legal Affairs

Corey Fishman — Chief Executive Officer

Judith Matthews — Chief Financial Officer

+2.6%1d on move date+0.7% vs SPY3d+53.2%5d+79.2%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ITRMF calls or request research access.

More ITRMF calls Browse calls Request research access